(Q73283449)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

G Doitsh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y Shaul

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

7506-7513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10602509%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203209

2 November 2019

exact match

0 references

cites work

The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

The hepatitis B virus X gene induces p53-mediated programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

c-abl has a sequence-specific enhancer binding activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

p53 in growth control and neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

High-level hepatitis B virus replication in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Biochemical properties and biological effects of p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Hepatitis B virus pX targets TFIIB in transcription coactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

The X protein of hepatitis B virus coactivates potent activation domains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Reversal of in vitro p53 squelching by both TFIIB and TFIID

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Human hepatitis B virus enhancer 1 is responsive to human interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Quantitative aspects of the formation and loss of DNA interstrand crosslinks in Chinese hamster cells following treatment with cis-diamminedichloroplatinum(II) (cisplatin). I. Proportion of DNA-platinum reactions involved in DNA crosslinking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Large Globin RNA Molecules and Their Processing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Functional inactivation but not structural mutation of p53 causes liver cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

A liver-specific enhancer in the core promoter region of human hepatitis B virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021

Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203209

7 January 2021